Merck KGaA agrees to buy Bio-Techne Corporation for $11.3 billion to strengthen its life-science business.
bloomberg-industries06/25, 04:51 PM
Related assets
Coming up for DHR
Explore next
Latest DHR news
MarketWatch07/30, 02:11 PM
Finnhub07/24, 09:33 PM
LiveSquawk07/21, 05:06 PM